Co-Authors
This is a "connection" page, showing publications co-authored by JEREMY J ERASMUS and HOMER A MACAPINLAC.
Connection Strength
1.452
-
Low-sensitivity FDG-PET studies: less common lung neoplasms. Semin Nucl Med. 2012 Jul; 42(4):255-60.
Score: 0.427
-
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. J Thorac Cardiovasc Surg. 2005 Jun; 129(6):1364-70.
Score: 0.262
-
Positron emission tomography imaging in nonsmall-cell lung cancer. Cancer. 2007 Nov 15; 110(10):2155-68.
Score: 0.078
-
PET/CT of esophageal cancer: its role in clinical management. Radiographics. 2007 Nov-Dec; 27(6):1635-52.
Score: 0.077
-
Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer. 2007 Jan 01; 109(1):125-34.
Score: 0.073
-
Integrated CT-PET imaging of esophageal cancer: unexpected and unusual distribution of distant organ metastases. Curr Probl Diagn Radiol. 2007 Jan-Feb; 36(1):21-9.
Score: 0.073
-
Attenuation correction of PET cardiac data with low-dose average CT in PET/CT. Med Phys. 2006 Oct; 33(10):3931-8.
Score: 0.072
-
Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol. 2006 Jun; 1(5):478-86.
Score: 0.070
-
Esophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy. J Thorac Imaging. 2006 May; 21(2):137-45.
Score: 0.070
-
Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR Am J Roentgenol. 2004 Oct; 183(4):1127-32.
Score: 0.062
-
Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? J Thorac Oncol. 2014 Aug; 9(8):1202-6.
Score: 0.031
-
Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol. 2012 Oct; 23(10):2638-2642.
Score: 0.027
-
Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma. AJR Am J Roentgenol. 2006 Jul; 187(1):W117-9.
Score: 0.018
-
Truncation artifact on PET/CT: impact on measurements of activity concentration and assessment of a correction algorithm. AJR Am J Roentgenol. 2006 May; 186(5):1458-67.
Score: 0.017
-
Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR Am J Roentgenol. 2006 Feb; 186(2):308-19.
Score: 0.017
-
Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer: normal variants and pitfalls. J Comput Assist Tomogr. 2005 Mar-Apr; 29(2):205-9.
Score: 0.016
-
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol. 2005 Feb 20; 23(6):1136-43.
Score: 0.016
-
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer. 2004 Oct 15; 101(8):1776-85.
Score: 0.016
-
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg. 2004 Oct; 78(4):1152-60; discussion 1152-60.
Score: 0.016
-
Teflon injection for vocal cord paralysis: false-positive finding on FDG PET-CT in a patient with non-small cell lung cancer. AJR Am J Roentgenol. 2004 Jun; 182(6):1587-9.
Score: 0.015